Φορτώνει......
Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience
BACKGROUND: Persistent significant proteinuria has been associated with increased risk of progression to end-stage kidney disease in patients with idiopathic membranous nephropathy (IMN). Rituximab (RTX) therapy has given encouraging results in IMN, but most of the studies have used a higher dose, w...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Clin Kidney J |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Oxford University Press
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007352/ https://ncbi.nlm.nih.gov/pubmed/29942496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfx105 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|